Bringing science and development together through news and analysis

  • We can learn from XDR-TB treatment in Lima


A new report from Lima, Peru, offers hope for tackling extensively drug-resistant tuberculosis (XDR-TB) in the developing world, says Mario C. Raviglione in the New England Journal of Medicine.

The report shows that with "aggressive and appropriate" management, XDR-TB can be cured in most cases.

Raviglione highlights some of the factors that may have contributed to Peru's success in treating the disease. All patients were given systematic drug-susceptibility tests and were treated with powerful second-line drugs, including a fluoroquinolone and an injectable drug. Where necessary, treatment regimens were reinforced with known effective drugs.

Strict community-based supervision was enforced, comprising psychological support, nutritional support and financial incentives. Additionally, intense bacteriological and clinical monitoring allowed for readjustments where necessary.

Raviglione believes that applying such an approach on a more global scale would help minimise, and effectively manage, drug resistance.

"In 2008, scaling up is indeed the major challenge faced by most complex health interventions worldwide … Effectiveness of a complex intervention depends on coordinated work among all forces."

Link to full article in The New England Journal of Medicine

We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.